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Objective: Lumbar facet joint degeneration (FJD) may be an important cause of low back pain (LBP) and
sciatica. The goal of this study was to characterize cellular alterations of inﬂammatory factor expression
and neovascularization in human degenerative facet joint capsular (FJC) tissue. These alterations in FJC
tissues in pain stimulation were also assessed.
Design: FJs were obtained from consented patients undergoing spinal reconstruction surgery and
cadaveric donors with no history of back pain. Histological analyses of the FJs were performed. Cytokine
antibody array and quantitative real-time polymerase chain reaction (qPCR) were used to determine the
production of inﬂammatory cytokines, and western blotting analyses (WB) were used to assay for
cartilage-degrading enzymes and pain mediators. Ex vivo rat dorsal root ganglion (DRG) co-culture with
human FJC tissues was also performed.
Results: Increased neovascularization, inﬂammatory cell inﬁltration, and pain-related axonal-promoting
factors were observed in degenerative FJCs surgically obtained from symptomatic subjects. Increased
VEGF, (NGF/TrkA), and sensory neuronal distribution were also detected in degenerative FJC tissues from
subjects with LBP. qPCR and WB results demonstrated highly upregulated inﬂammatory cytokines, pain
mediators, and cartilage-degrading enzymes in degenerative FJCs. Results from ex vivo co-culture of the
DRG and FJC tissue demonstrated that degenerative FJCs increased the expression of inﬂammatory pain
molecules in the sensory neurons.
Conclusion: Degenerative FJCs possess greatly increased inﬂammatory and angiogenic features, sug-
gesting that these factors play an important role in the progression of FJD and serve as a link between
joint degeneration and neurological stimulation of afferent pain ﬁbers.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved..-J. Im, Rush University Medical Center, Cohn Research BD 516, 1735 W. Harrison St., Chicago, IL 60612, USA. Tel: 1-312-
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Back pain ranks among the most common medical conditions
afﬂicting American adults. The lifetime prevalence is about
70e85%, with 10e20% experiencing chronic low back pain (LBP)1.
Facet joint degeneration (FJD) as a source of LBP is often called ‘facet
joint syndrome’. FJD arising from osteoarthritic changes, which is a
common cause of LBP with an incidence of 15e45% among patients
with chronic LBP2e6, has been extensively reviewed in recent
articles7,8.
Facet joints (FJs) are paired zygophyseal joints between two
consecutive vertebrae. The paired FJs and their corresponding
intervertebral disc comprise a ‘three-joint complex’ constituting a
‘spinal motion segment’7. FJs are subject to compressive, shear, and
axial loading at the spinal motion segment. FJD may be associated
with intervertebral disc degeneration9e12. The FJ consists of hyaline
cartilage, menisci, synovium, and joint capsule. The medial branch
of the dorsal primary ramus courses through the FJ and distributes
sensory innervation. The human facet joint capsular (FJC) tissue,
deﬁned as the ﬁbrous connective tissue lined with synovium sur-
rounding the joint, is richly innervated with nociceptive nerve ﬁ-
bers, autonomic nerve ﬁbers and mechanoreceptors13e15.
Additionally, the FJ lies in close proximity to the dorsal root gan-
glion (DRG)16.
Cytokine mediators of inﬂammation, angiogenesis, sensory
neuron ingrowth and pain have been implicated as participants in
joint degeneration17e20. Pathologic loading, which has been asso-
ciated with the production of cytokines associated with inﬂam-
mation, angiogenesis, sensory neuron ingrowth and pain in joint
tissues21e23, is associated with FJD24,25. Studies have shown that
LBP may result from facet hypertrophy, inﬂammation, or degrada-
tion; however, the precise relationship between FJC tissues and LBP
is not completely understood26e29.
Previous studies have demonstrated cytokine release from
degenerative FJs and that the levels released are proportional to the
LBP symptoms of patients30,31. Other joints, such as the knee, have
been shown to exhibit neovascularization in association with
degeneration. Angiogenesis and associated nerve growth are linked
to joint degeneration and pain17e20; its underlying mechanisms
contributing to FJD require further study. The mechanisms by
which FJD progresses to pain formation remain unclear and are the
subject of continued investigation.
The goal of this study is to investigate the inﬂammation,
angiogenesis, neuronal ingrowth and pain mediators that occur in
FJC tissues obtained from subjects with chronic LBP with degen-
erative FJs. Additionally, to study functional mechanisms and po-
tential cellular communication between peripheral tissues and
sensory neurons, an ex vivo organ co-culture system using degen-
erative FJC tissues and rat lumbar DRGs was developed.
Methods
Human spine tissue acquisition
Donor tissues: Consented asymptomatic organ donor tissue
samples were obtained from the Gift of Hope Tissue Network
(Elmhurst, Illinois) within 24 h of death. The Gift of Hope Tissue
Network provided clinical information about the organ donors
from hospital charts and personal history from next of kin. Lumbar
spine segments from those donors with no reported clinical back
pain symptoms were harvested for our experiments. Each lumbar
segment was examined by magnetic resonance imaging (MRI).
Intact FJs were removed and processed aseptically. FJC tissues were
harvested and the cartilage was visually graded for degeneration
from grade 0 (normal), 1e2 (early degeneration) to 3e4 (advanceddegeneration) according to the scale developed by Collins et al.32 in
conjunction with an established MRI grading system for FJD10.
Surgical tissues: After obtaining Institutional Review Board (IRB)
approval and patient consent, intact FJs were removed from pa-
tients with LBP undergoing routine spinal fusion and supplied to us
by the Orthopedic Tissue Repository. The FJs were then graded as
described above. Tissue sources and detailed tissue information are
listed in Table I.
Western blotting (WB)
Total protein from human FJC tissues was extracted using cell
lysis buffer (Cell Signaling, Danvers, MA, USA), following the in-
structions provided by the manufacturer. Protein concentrations of
human FJC tissues were determined by the bicinchoninic acid
protein assay (Pierce, Rockford, IL, USA). Equal amounts of protein
(30 mg protein/well) were separated by 10% SDS-PAGE and then
electroblotted onto nitrocellulose membranes for western blot
analyses. Immunoreactivity was visualized using the ECL system
(Amersham Biosciences, Piscataway, NJ, USA).
Reverse transcription (RT) and real-time polymerase chain reaction
Total RNA was isolated using Trizol reagent (Invitrogen, Carls-
bad, CA, USA), following the instructions provided by the manu-
facturer. RT was carried out with 1 mg total RNA, using the
ThermoScript™ RT-PCR system (Invitrogen) for ﬁrst strand cDNA
synthesis. For real-time PCR, cDNA was ampliﬁed using the MyiQ
Real-Time PCR Detection System (Bio-Rad Hercules, CA, USA). A
threshold cycle (Ct value) was obtained from each ampliﬁcation
curve using iQ5 Optical System Software provided by the manu-
facturer (Bio-Rad). Relative mRNA expression was determined us-
ing the DDCT method, as detailed by manufacturer (Bio-Rad). The
primer sequences and their conditions will be provided upon
request.
Cytokine antibody array and quantiﬁcation
An array for cytokine proteins (Cytokine Array, RayBio, Norcross,
GA, USA) was used to determine alterations in cytokine levels. For
the microarray assay, the directions provided by the manufacturer
were precisely followed. Brieﬂy, the membranes were incubated
with 2mL of a 1X blocking buffer at room temperature for 30min to
block membranes. After decanting the blocking buffer, the mem-
branes were incubated overnight at 4C with either 500 mg total
protein extracted from asymptomatic donor controls (FJ grade 0 or
1 with no sign of capsular hypertrophy) or surgical FJC tissues from
subjects with symptomatic LBP, followed by biotin-conjugated
antibodies. After decanting, all membranes were washed three
times with 2 mL of 1X wash buffer I at room temperature for 5 min,
followed by washing twice more with 1X wash buffer II at room
temperature. Then, all membranes were incubated with a dilution
(1:250) of biotin-conjugated antibodies at room temperature for
2 h, and the washing steps were repeated. To visualize andmeasure
the immunoreactivity, these membranes were further incubated
with horseradish-peroxidase (HRP)-conjugated streptavidin.
Immunoreactivity was visualized using the ECL system (Amersham
Biosciences, Piscataway, NJ, USA) and the Signal Visual Enhancer
system (Pierce) to magnify the signal intensity. Densitometric
measurements were performed by calculating the integrated den-
sity values (area relative intensity) for each spot using the Molec-
ular Imager VersadocMP 4000 System (Bio-Rad) and Quantity One-
4.5.0 Basic 1-D Analysis Software (Bio-Rad). The positive control
signals of each membrane were used to normalize signal intensity.
Table I
Demographics of collected facet joints
Sample type Age Gender Symptom FJ grade
Clinical sample
(surgically removed)
77Y F Osteoporosis, degenerative facets, spinal stenosis with severe back pain G4
82Y M Severe spinal stenosis, degenerative facet with severe back pain G4
47Y M Lateral recess stenosis with severe back pain G4
67Y F Degenerative scoliosis and spondylolisthesis with severe back pain G4
78Y M Spondylolisthesis, spinal stenosis, degenerative facet, severe back pain G4
30Y M Degenerative disc disease and low back pain G3
39Y M Disc degeneration with severe back pain, a traumatic low back injury G3
80Y F Degenerative spondylosis with low back pain, Degenerative facet G4
63Y F Spondylolisthesis, spinal stenosis, degenerative facets, low back pain G4
31Y M Severe low back pain G3
57Y F Degenerative lumbar scoliosis G3
77Y F Spondylolisthesis, highly degenerated facet joint G3
75Y F Spinal stenosis with bilateral leg and back pain G4
62Y M Degenerative scoliosis, L3/L4 spondylolisthesis, L3/L4 lumbar stenosis, low back pain G4
70Y F Severe low back pain, Severe facet joint degeneration G4
56Y M Severe facet joint degeneration, low back pain G3
74Y F Severe facet joint degeneration, low back pain G3
Cadaver 61Y M Loss of cartilage exposing the underlying bone, Bilateral L3/4 facet G4
Surface ﬁssures to deep zone, Left L4/5 facet G3
21Y F Intact surface, Bilateral L3/4 facet G0
Intact surface, Bilateral L4/5 facet G0
48Y F Surface ﬁssure, Bilateral L3/4 facet G1
Surface ﬁssure, Bilateral L4/5 facet G1
48Y M Surface ﬁssures to deep zone, Left L4/5 facet G3
Surface ﬁssures to mid zone Bilateral L4/5 facet G2
50Y M Surface ﬁssures to mid zone, Right L4/5 facet G2
56Y M Surface ﬁssures to deep zone, Left L3/4 facet G3
Complete destruction, Bilateral L4/5 facet G4
44Y F Surface ﬁssures to mid zone Bilateral L3/4 facet G2
Surface ﬁssures to mid zone Bilateral L4/5 facet G2
28Y F Intact surface, Bilateral facet L3/4 G0
Surface ﬁssure, Bilateral L4/5 fact G1
33Y M Surface ﬁssures, Bilateral L3/4 facet G1
Surface ﬁssures, Bilateral L4/5 facet G2
53Y F Surface ﬁssures to deep zone, Left L3/4 facet G3
Surface ﬁssures to mid zone, Left L4/5 facet G2
65Y M Complete destruction, Bilateral L4/5 facet G4
Grading n number Age Gender Tissue type
Male Female Clinical Cadaver
G:0 3 23.3 ± 4 0 3 0 3
G:1 6 36 ± 9 3 3 0 4
G:2 6 45 ± 7 3 3 0 6
G:3 7 53 ± 7 4 3 5 4
G:4 15 69 ± 10 7 8 12 3
Total 37 53 ± 17 17 20 17 20
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Human lumbar FJs were ﬁxed in 4% paraformaldehyde for 72 h,
and decalciﬁed in a 22% formic acid and 10% citric acid solution,
changed every 4 days until the bone tissues were soft. The
decalciﬁed FJ tissues were cut in the transverse plane and parafﬁn-
embedded. Serial FJ sections, exactly 5 mm thick, were cut to
prepare slides. Safranin-O Fast Green staining was used to assess
general morphology and loss of proteoglycan in the cartilage
ground substance. Alcian Blue Hematoxylin/Orange G staining was
used to assess general morphology and structural changes. The
following primary antibodies were used for immunohistochemical
(IHC) staining: anti-vascular endothelial growth factor (VEGF)
(ab39250; Abcam, Cambridge, MA, USA); a-smooth muscle actin
(a-SMA) (ab5694, Abcam); CD11b (Santa Cruz Biotechnology,
Dallas, TX, USA); neuroﬁlament-M (NF-M) (Thermo Scientiﬁc,
Waltham, MA, USA); and nerve growth factor (NGF)/tropomyosin
receptor kinase A (TrkA) (Abcam). IHC was carried out using the
standard avidin-biotin-peroxidase complex technique. Sections
were then visualized using the Vectastain Kit (Vector Laboratories,
Burlingame, CA, USA), followed by counterstaining with Hema-
toxylin. For immunoﬂuorescence staining, a ﬂuorescent-labeledsecondary antibody was added and slides were incubated at
room temperature for 1 h in darkness. Sections were rinsed in
phosphate-buffered saline (PBS), mounted in anti-fading
mounting media (Vector Laboratories), and examined using an
Olympus BX43 upright microscope (Olympus Optical, Center Val-
ley, PA, USA).DRG co-culture
Adult Sprague-Dawley rats (250e300 g) without pain symp-
toms were euthanized with carbon dioxide. Bilateral lumbar DRGs
from L1 to L5 (10 DRGs per rat) were carefully removed by aseptic
dissection under stereoscopic microscopy, with particular care
taken to avoid physical damage. Three randomly selected rat DRGs
were placed into individual wells and co-cultured in DMEM media
containing 1%mini-ITS,1% GlutaMAX, and 1% HEPES for 5 dayswith
normal or degenerative FJC tissues or media control. Each experi-
mental group comprised three wells with media control, or unique
normal or degenerative FJC tissues in each well. The three DRGs in
each well were harvested for RNA extraction and PCR as previously
described33.
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SPSS for Windows (Version 12.0, IBM Corporation, Somers, NY)
and SAS (version 9.2, SAS Institute, Cary, NC) were used to calculate
descriptive statistics, to test group differences and to correct for
error inﬂation due to multiple testing. For variables that have
approximately normal distributions and similar variances, a two-
sided t-test was used to compare groups. To adjust for the prob-
lem of error inﬂation due to multiple hypothesis testing we used an
adjustment method to control the false discovery rate (FDR) as
described by Benjamini and Hochberg (1995)34. The P-values,
grouped by analytical section, were adjusted using linear step-up
adjustments in a manner that controls the FDR, hence mini-
mizing issues of error inﬂation. A P  0.05 signiﬁcance level, after
adjustment for error inﬂation, was used for all statistical tests. In-
dividual P-values represented in the ﬁgures. Data represented as
mean. Error bars represented as 95% conﬁdence interval (CI).
Results
Gross and histologic appearance of human FJD
Gross appearances of human FJs were examined and assigned a
representative grade for the appearance of the inferior facet
(Collin's grades: G0eG4; Fig. 1A and B)32,35. Samples with higher
grades showed an increase in the size of edge osteophytes, reactive
bone, and cartilage eburnation. The symptomatic surgical samples
clearly had the most degenerative morphological changes (Table I).
The gross appearance of human FJs was further analyzed by his-
tological examination for proteoglycan content by comparing
normal (G0) with degenerated facets with different grades ofB. Gross Appe
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Fig. 1. Gross and histologic appearances of normal and degenerative FJs. A, Anatomical st
Gross appearances of FJs and FJC tissues. Each FJ was assigned a representative grade for the a
in the size of edge osteophytes, reactive bone, and cartilage eburnation. C, Safranin O, D, Alcia
severe depletion of proteoglycan, ﬁbrillation, structural and morphological changes in degen
least n ¼ 3 for G0 and n ¼ 6 for each grades, G2-4.pathological conditions (G2-4). Safranin O staining revealed severe
depletion of proteoglycan in FJs with advanced degeneration (G3/4)
compared to normal joints (G0) (Fig. 1C). Alcian Blue Hematoxylin/
Orange G and H&E staining results of the FJs further supported
observations of the structural and morphological changes corre-
lated with grade (Fig. 1D and E).
Inﬂammation is increased in degenerative FJC tissues
Results of staining for CD11b, amarker of immune cell inﬁltration,
indicated inﬁltration of inﬂammatorycells indegenerative FJC tissues
(Fig. 2A). We examined the expression of cytokines in degenerative
FJC tissues (G3/4) compared to normal FJC tissues (G0). Results from
cytokine antibodyarrayanalyses revealed a signiﬁcant increase in the
levels of multiple pro-inﬂammatory cytokines, including GROa,
sICAM-1, INF-g, IL-1b, IL-17, RANTESandTNFa (P<0.01) and IL-1a, IL-
17E (P< 0.05), aswell as an increase in the level of anti-inﬂammatory
cytokines IL-10 and IL-13 (P < 0.05) (Fig. 3A).
Quantitative real-time PCR (qPCR) analysis was employed to
support the cytokine antibody array data. The results demonstrated
that the induced protein levels correlated with increased mRNA
levels of pro-inﬂammatory cytokines (Fig. 3B). Our individual qPCR
data revealed slight differences between mRNA and protein levels
assessed by the cytokine antibody array. For example, we did not
observe signiﬁcant upregulation of IL-8, CCL2, and IL-1Ra at the
protein level, but RNA levels were signiﬁcantly increased in
degenerative FJC tissues (P < 0.05) (Fig. 3B). qPCR analyses also
found signiﬁcant upregulation of additional pro- and anti-
inﬂammatory cytokines that were not analyzed in the cytokine
assay system, including IL-18 and IL-11, and toll-like receptors TLR2
and TLR4 (P < 0.05) (Fig. 3B).G:0 G:2 G:3 G:4 
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Fig. 2. Assessment of inﬂammation, neovascularization, and neuron ingrowth in normal and degenerative FJC tissue. A, Immunohistochemical (IHC) staining of CD11b in-
dicates increased inﬁltration of inﬂammatory cells in degenerative FJC tissues (G3/4) compared to normal FJC tissues (G0). B, IHC staining of smooth muscle actin (a-SMA) shows
markedly increased angiogenic events in degenerative FJC (G3/4) tissues compared to normal FJC tissues (G0). C, IHC staining of VEGF (upper panel) and WB analyses (lower panel)
show increased induction of VEGF in degenerative FJC tissue (G3/4) compared to NFJC tissues (G0). D-F, IHC results demonstrate substantially increased neuro-ﬁlament-M (NF-M; a
marker of neurite formation), neuronal growth promoting factor, NGF, and its cognate receptor TrkA in degenerative FJC (G3/4) compared to normal FJC tissues (G0). These results
represent at least n ¼ 3 for normal FJC tissue and n ¼ 6 for degenerative FJC tissue (G1~4).
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Markedly increased neovascularization was evident in the
degenerative FJC tissues, as assessed by immunoreactivity for a-
SMA (Fig. 2B). When comparing normal (G0) or early FJ degener-
ation (G1) with advanced degenerative FJC tissues (G3/4), neo-
vascularization was clearly increased. These angiogenic events
correlated with an increase in VEGF expression, assessed by
immunohistochemistry (Fig. 2C; upper panel) and western blot
analyses (Fig. 2C; lower panel).
Neurogenesis is increased in degenerative FJC tissues
In the advanced stage of degenerative FJC tissues (G3/4)
compared to normal (G0) or early stage of degenerative tissues
(G1), IHC results demonstrated that neuroﬁlament-M (NF-M; amarker of neurite formation) was substantially increased (Fig. 2D).
Correspondingly, our results revealed that the NGF/TrkA axis is
highly upregulated in the advanced degenerative stage of FJC tis-
sues, as assessed by IHC (Fig. 2E and F), as well as by qPCR analyses
for mRNA levels of NGF and TrkA (P < 0.01) (Fig. 5C).
Degenerative FJC tissues overexpress cartilage-degrading enzymes
and tissue inhibitors of metalloproteinases (TIMPs)
We examined levels of key cartilage-degrading matrix metal-
loproteinases (MMPs) and aggrecanases, such as MMP-13, MMP-1,
MMP-3, ADAMTS-4 and ADAMTS-5, by comparing normal with
degenerative FJC tissues. Collagenases (MMP-1, MMP-13) and
stromelysin (MMP-3) were highly upregulated in degenerative FJC
tissues at both mRNA (Fig. 4A, P < 0.01) and protein levels [Fig. 4A0].
Similarly, critical aggrecanases, ADAMTS-4 and ADAMTS-5, were
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Fig. 3. Cytokine proﬁling in normal and degenerative facet joint capsular (FJC) tissues. A, Densitometric Analyses of Cytokine Antibody Array, using FJC tissue lysates from
normal (G0) and degenerative FJ tissues (G3/4). The histogram shows levels of altered cytokines in degenerative FJC tissues (n ¼ 10) relative to normal FJC tissues (n ¼ 3). B,
Quantitative real-time PCR analyses for comparative gene expression proﬁle of pro- and anti-inﬂammatory cytokines and TLRs, between normal FJC tissues (G0) (NFJC, n ¼ 3) and
degenerative FJC tissues (DFJC, G3/4) (n ¼ 10). Individual P-values represented in the ﬁgures. Data represented as mean. Error bars represented as 95% CI.
J.-S. Kim et al. / Osteoarthritis and Cartilage 23 (2015) 2242e2251 2247signiﬁcantly increased at both mRNA (Fig. 4B, P < 0.05) and protein
levels [Fig. 4B0]. Modulation of gene expression was not limited to
cartilage-degrading enzymes; we also observed striking induction
of TIMPs, family members that antagonize cartilage-degrading
enzyme activities in the degenerative FJC tissues. These included
TIMP-2 and TIMP-3 at mRNA (Fig. 4C, P < 0.05) and protein levels
(Fig. 4C0). We did not observe a signiﬁcant increase in TIMP-1 in
degenerative FJC tissues (Fig. 4C).
Degenerative FJC tissues overexpress pain-related molecules and
inﬂuence the expression of pain mediators in sensory neurons in an
ex vivo DRG organ co-culture model
We further examined whether FJC tissues from degenerative FJs
overexpress pain-related molecules. Our real-time PCR and WB
analyses revealed signiﬁcant increases in both mRNA and protein
levels in inﬂammatory pain mediators inducible nitric oxide syn-
thase (iNOS) and cyclooxygenase-2 (COX-2) (Fig. 5A, P < 0.05).
Among the subtypes of prostaglandin receptors, expression levels
of EP1, EP3 and EP4 were signiﬁcantly (P < 0.05) elevated in
degenerative FJC tissues (G3/4) compared to normal (G0). Unex-
pectedly, the level of EP2 was reduced in degenerative FJC tissuescompared to normal at both mRNA (P < 0.05) and protein levels
(Fig. 5B).
Signiﬁcant increases in expression of neuromodulators,
including substance P, calcitonin gene-related peptide (CGRP), NGF,
TrkA, and pain-associated ion channel transient receptor potential
cation channel subfamily V member 1 (TRPV1), were found in
degenerative compared to normal FJC tissues (Fig. 5C; P < 0.05 or
P < 0.01). Our DRG co-culture model revealed that degenerative FJC
tissues signiﬁcantly altered the production of pain mediators in
DRGs, reﬂected by the overexpression of substance P (P < 0.05) and
NGF (P < 0.01; Fig. 5D).Discussion
Our results revealed that FJC tissues harvested from degenera-
tive FJs from subjects with LBP displayed higher levels of angio-
genesis, inﬂammation, and neurogenesis when compared to
healthier FJC tissues harvested from asymptomatic donors. Addi-
tionally, degenerated FJC tissues greatly overexpressed pain-related
molecules that may prompt DRG neurons to increase pain
sensitization.
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Fig. 4. Expression of cartilage degrading enzymes and TIMPs in normal and degenerative FJC tissues. Comparison of MMPs, ADAMTSs, and TIMPs assessed by quantitative real-
time PCR for mRNA levels (A-C, n ¼ 3 normal (NFJC, G0); n ¼ 12 degenerative FJC (DFJC, G3/4) tissue) (AeC) and WB for protein (n ¼ 3 NFJC; n ¼ 3 DFJC) (A0eC0). Individual P-values
represented in the ﬁgures. Data represented as mean. Error bars represented as 95% CI.
J.-S. Kim et al. / Osteoarthritis and Cartilage 23 (2015) 2242e22512248Elevated levels of pro-inﬂammatory cytokines, as well as
cartilage-degrading enzymes, seen in degenerative FJs (G3/4)
compared to normal FJs (G0) strongly support the proposition that
these molecules play roles in structural and molecular changes in
FJC tissues and in adjacent FJs. Nevertheless, it must be noted that
not only pro-inﬂammatory cytokines and cartilage-degrading en-
zymes, but also anti-inﬂammatory cytokines and inhibitors of
cartilage-degrading enzymes, including IL-10, IL-13, TIMP-2 and
TIMP-3, are upregulated in parallel. Similar observations have been
noted in other human joint structural tissues, suggesting that this
may be an unsuccessful attempt of the reparative response to
overcome the degenerative process36e38.
Recent studies have implicated angiogenesis as having a
principal role in the development of joint degenerative disease
and pain through stimulation of inﬂammation and
innervation39e41. It has been suggested that the inﬂux of inﬂam-
matory cells into the joint resulting from of angiogenesis may
exacerbate degeneration and lead to LBP42,43. Angiogenesis, itself,
promotes the ingrowth of new sensory nerve ﬁbers and is a
possible cause of enhanced pain perception17,18,20. An upregula-
tion of angiogenic factors, inﬂammatory cytokines, immune cellinﬁltration, and newly formed sensory nerve ﬁber ingrowth
within the FJC of symptomatic patients may be indicative of a
progressive pattern leading from the initiation of FJ degeneration
to pain production.
Newly formed sensory nerve ﬁbers found in degenerative FJs
respond to inﬂammation and, additionally, initiate or facilitate
inﬂammation through the release of vasoactive substances into the
joint44e46. The close proximity of the FJ to the DRG may enhance
these “crosstalk” capabilities. Damage to the FJ leads to the release
of inﬂammatory cytokines and pain-mediators by sensory neurons
in the DRGs; consequently, these released molecules become crit-
ical compounding factors in nocioceptive changes in degenerative
FJs47,48. Our DRG co-culture model demonstrates that degenerative
FJC tissues modify the functional properties of sensory neurons in
the DRG, as seen by the overproduction of the critical pain medi-
ators substance P and NGF. Our results suggest that “crosstalk”
between the degenerated FJ and DRG, in combination with the
upregulation of inﬂammatory neuropeptides, receptors, and ion
channels (e.g., substance P, COX-2, CGRP, EP receptors, TRPV1 and
the NGF/TrkA axis) exacerbate pain production in symptomatic LBP
patients.
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Fig. 5. The level of inﬂammatory pain mediators and pain neuromodulators in normal and degenerative FJC tissues. Comparison of A, COX-2, iNOS; B, prostaglandin (EP)
receptors; and C, pain neuromodulator (CGRP, Substance P, TRPV1, NGF, TrKA) expression in degenerative FJC tissue (G3/4, DFJC) as compared to normal FJC tissue (G0, NFJC), which
was assessed by quantitative real-time PCR for mRNA (n ¼ 3, NFJC; n ¼ 10 DFJC tissue) and WB for protein (n ¼ 3 NFJC tissue; n ¼ 3 DFJC tissue). D, isolated rat DRGs were co-
cultured with media control (M), NFJC tissue, or DFJC tissue for 5 days. Assessment of total relative gene induction was assessed by quantitative real-time PCR analyses of sub-
stance P and NGF in DRGs. The data represent three independent experiments (n ¼ 3 donors) with triplicates. Individual P-values represented in the ﬁgures. Data represented as
mean. Error bars represented as 95% CI.
J.-S. Kim et al. / Osteoarthritis and Cartilage 23 (2015) 2242e2251 2249We previously reported that TIMP-3, the most potent chon-
droprotective molecule among the four TIMP family members
(TIMP1~4), is signiﬁcantly reduced in osteoarthritic knee cartilage
compared to normal knee cartilage49. However, in the present
study, we observed that TIMP-3 is one of the molecules that was
greatly increased in degenerative FJC tissues compared to normal.
In addition, we also found a signiﬁcant reduction in prostaglandin
E2 receptor EP2 in degenerative FJC tissues. The EP2 receptor is
highly upregulated in degenerative knee joint cartilage, and is
known to be linked to the pathophysiology of cartilage50. These
results suggest there may be tissue-speciﬁc differential expression
patterns of these molecules.
While this study produced important results, there are limita-
tions thatmust be considered. First, limitationsmay exist due to the
small sample size, especially for normal tissues (G0). Obtaining a
large sample population proved difﬁcult because samples were
acquired surgically from consented patients or from cadaveric or-
gan donors. Second, there was limited personal information avail-
able from the cadaveric donors because pain scores directly
resulting from LBP were not available. Third, there may beincongruities in the DRG co-culture model because of the use of rat
DRGs with human FJC tissues. Continuing studies using the DRG co-
culture system to examine other targets should prove beneﬁcial to
the understanding of “crosstalk” between peripheral tissues and
the sensory nerve system.
In summary, our data suggest that increased inﬂammatory and
angiogenic features in degenerative FJC tissues play an important
role in the progression of FJD and serve as a link between joint
degeneration and neurological stimulation of afferent pain ﬁbers.
Reproducing symptomatic FJD leading to FJ pain in animal models
will greatly enhance our understanding of translational or pre-
clinical information that cannot be answered from human clinical
studies.
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